| Date | Title | Description |
| 03.07.2025 | Activist Starboard Value takes stake in online travel company Tripadvisor, stock jumps | Activist Starboard Value takes stake in online travel company Tripadvisor, stock jumps
By ReutersJuly 2, 202511:22 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Tripadvisor app is seen on a sm... |
| 02.07.2025 | FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff | Related Articles
New CIA report criticizes investigation into Russia’s support for Trump in 2016
Trump to meet at White House with American hostage freed from Gaza
Florida’s ‘Alligator Alcatraz’ detention center is set to receive its first ... |
| 01.07.2025 | The AI Revolution in Drug Discovery: A New Era of Innovation | The landscape of drug discovery is undergoing a seismic shift. Two companies, XtalPi and Chai Discovery, are at the forefront of this transformation. They are harnessing the power of artificial intelligence (AI) to redefine how we approach ... |
| 01.07.2025 | The Future of Vaccines and Antibodies: A New Era in Medicine | In the world of medicine, innovation is the lifeblood that keeps the industry vibrant. Two recent breakthroughs showcase the power of science and technology in fighting diseases: Moderna's promising flu vaccine and Chai Discovery's revoluti... |
| 01.07.2025 | The Future of Vaccines and Drug Discovery: A New Era in Healthcare | In the ever-evolving landscape of healthcare, two recent developments stand out: Moderna's promising flu vaccine and the collaboration between XtalPi and Pfizer in drug discovery. Both stories reflect a shift towards innovation, driven by t... |
| 01.07.2025 | The Gene Revolution: Laverock Therapeutics and AbbVie’s Bold Moves in Biotech | In the ever-evolving landscape of biotechnology, two stories stand out like beacons of innovation. Laverock Therapeutics, a London-based startup, has raised over €23.3 million to advance its gene control technology. Meanwhile, AbbVie, a gia... |
| 30.06.2025 | Американский AbbVie покупает разработчика клеточной терапии Capstan за $2,1 млрд | Американский производитель лекарств AbbVie потратил более $20 млрд на приобретения с 2023 года, когда его флагманский препарат для лечения ревматоидного артрита Хумира утратил патентную защиту.
Capstan разрабатывает CAR-T-терапию, которая и... |
| 30.06.2025 | XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations | CAMBRIDGE, Mass., June 30, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, ann... |
| 30.06.2025 | Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot | Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial.
The positive data pave the way for Moderna to apply for approval of its standalone... |
| 30.06.2025 | Chai Discovery Unveils Chai-2 Breakthrough, Achieving Fully De Novo Antibody Design With AI | Chai Discovery, which builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules, announced a breakthrough in the de novo design of antibodies. The company’s latest model, Chai-2, demonst... |
| 28.06.2025 | Bank of America says buy these five stocks that are set to rally in the second half | - |
| 27.06.2025 | 3 forces driving a record week for stocks as 7 portfolio names hit new highs | - |
| 27.06.2025 | A rundown of recent Trump administration vaccine policy changes | But the group also said people should avoid shots containing thimerosal, a preservative used only in large multi-dose vials that has been proven to be safe. The ingredient isn’t used in single-dose flu shots, the type of syringe used for ab... |
| 26.06.2025 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 26.06.2025 | DemeRx Appoints Biopharma Industry Veteran Vic Pirotsky to Board of Directors | Pirotsky brings more than two decades of biopharma expertise and a proven track record of leading 8+ successful new drug applications •He advocates for an "Addiction Moonshot" collaboration between government and business •Appoint... |
| 26.06.2025 | Miss Illinois Teen USA Emcees Chicago Miles for Melanoma 5K to Raise Critical Funds for Melanoma Research | The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be ho... |
| 25.06.2025 | These are the stocks that led the S&P 500′s incredible comeback from the April lows | - |
| 23.06.2025 | Medison and Everest Medicines: Pioneering the Future of Global Biotech | In the ever-evolving landscape of biotechnology, two companies are making significant strides: Medison and Everest Medicines. Both are reshaping the way therapies reach patients, particularly in underserved markets. Their recent development... |
| 23.06.2025 | OnCusp Therapeutics Appoints Dimitry Nuyten, M.D., Ph.D., as Chief Medical Officer | PRINCETON, N.J., June 23, 2025 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients, tod... |
| 23.06.2025 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 20.06.2025 | Everest Medicines Announces Successful Release of First Clinical Batch of Tumor-Associated Antigen Vaccine EVM14 at Jiashan Manufacturing Site | SHANGHAI, June 20, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of i... |
| 19.06.2025 | Big Pharma Under Fire: A Taxing Debate in the Senate | The Senate floor is heating up. Two Democratic lawmakers, Sen. Elizabeth Warren and Rep. Jan Schakowsky, are shining a spotlight on the pharmaceutical giants. Pfizer, Johnson & Johnson, Merck, AbbVie, and Amgen are in the crosshairs. Th... |
| 18.06.2025 | The Dawn of Radioligand Therapies: A New Era in Precision Oncology | In the realm of cancer treatment, innovation is the lifeblood that fuels hope. The latest beacon of this hope shines brightly on radioligand therapies (RLTs). These therapies are not just a whisper of potential; they are a clarion call for ... |
| 18.06.2025 | Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer | Strategic appointments reflect Medison's continued investment in global scale and operational excellence
PETACH TIKVA, Israel, June 18, 2025 /PRNewswire/ -- Medison, the creator of a first-of-its-kind unified global commercialization platfo... |
| 17.06.2025 | Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump’s plan | Two Democratic lawmakers on Tuesday pressed five of the nation’s largest pharmaceutical companies about their low tax bills and whether they support extending massive tax cuts for the industry in the GOP reconciliation bill.
Sen. Elizabeth ... |
| 16.06.2025 | Citi recommends these rare stocks that will show profitability gains this year | - |
| 14.06.2025 | Israel-Iran attacks and the 2 other things that drove the stock market this week | - |
| 13.06.2025 | Signify Bio: $15 Million Raised For Creating Personalized Medicines | Signify Bio, which is a pioneering biotechnology company harnessing the human body for the production of in situ protein therapeutics, announced an oversubscribed $15 million initial financing.
The funding round was led by Actium Group with... |
| 13.06.2025 | Indianapolis-based startup leans on connections to treat brain diseases | Please subscribe to IBJ to decode this article.
so" co7tniifn:wct=l l5m=/nne4bBc_omtI"/ioaedel"-_oii=ii0-edidC5a2ru["00-mca5ae=fud othmtwi1ga"e"3r"daletl0ca]nsene d vy.sdstiheip =loto jee6teo mpts m3t [c6i... |
| 12.06.2025 | Немецкая BioNTech приобретает конкурирующую CureVac за $1,25 млрд | В соответствии с согласованной сделкой, которая объединяет двух бывших конкурентов в гонке за разработку вакцины от COVID-19, каждая акция CureVac будет обменена примерно на $5,46 в американских депозитарных акциях (ADS) BioNTech, сообщает ... |
| 12.06.2025 | Why Apple, Microsoft, Pfizer and other U.S. multinational corporations set up shop in Ireland | There are 973 U.S. firms with operations in Ireland, according to the American Chamber of Commerce Ireland. Members of President Donald Trump’s administration have signaled that some of that activity should return to the states.
“They have ... |
| 11.06.2025 | Why a Covid-19 vaccine could soon cost as much as $150—even if you’re insured | If you’re planning on getting a Covid-19 booster this fall, you could be faced with a hefty bill — even if you have insurance.
Health and Human Services Secretary Robert F. Kennedy Jr. announced in May that the Centers for Disease Control a... |
| 10.06.2025 | Drug pricing reform talks with US government lack clarity, industry executives say | Drug pricing reform talks with US government lack clarity, industry executives say
By Bhanvi Satija and Christy SanthoshJune 10, 20258:34 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 o... |
| 09.06.2025 | Stocks tick higher as investors await details on U.S.-China trade talks progress: Live updates | Stocks edged higher Tuesday as investors waited for more insight on trade discussions between the U.S. and China.
The Dow Jones Industrial Average added 82 points, or 0.2%. The S&P 500 rose around 0.3% along with the Nasdaq Composite.
T... |
| 09.06.2025 | No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says | No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says
By Michael ErmanJune 9, 20253:52 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Pfizer logo is seen in this ... |
| 09.06.2025 | FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca | The Food and Drug Administration approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus.
The decision will allow the company to launch the drug, which will be marketed as En... |
| 09.06.2025 | BIOSeedin Innovation Partnering Conference 2025: Spotlight on China's Biopharma Trailblazers and Global Collaboration | China's influential innovative drug asset cooperation platform
NEWARK, Del., June 9, 2025 /PRNewswire/ -- BIOSeedin Innovation Partnering Conference (BIOS), established in 2021, has quickly become one of the most prestigious biopharmaceutic... |
| 07.06.2025 | China’s Biopharma Surge: A New Era of Innovation and Collaboration | In the world of biopharmaceuticals, China is no longer a mere follower. It is a leader, a trailblazer, and a powerhouse of innovation. The recent BIOSeedin Innovation Partnering Conference (BIOS) held in Newark, Delaware, is a testament to ... |
| 07.06.2025 | Jobs, profit-taking and 2 other things that drove the stock market this week | - |
| 06.06.2025 | BIOSeedin Innovation Partnering Conference 2025: Spotlight on China's Biopharma Trailblazers and Global Collaboration | NEWARK, Del., June 6, 2025 /PRNewswire/ --
China's influential innovative drug asset cooperation platform
BIOSeedin Innovation Partnering Conference (BIOS), established in 2021, has quickly become one of the most prestigious biopharmaceutic... |
| 06.06.2025 | JPMorgan’s top biotech and pharma picks for the second half | - |
| 05.06.2025 | QureBio Ltd. Completes Nearly CNY 100 Million Series C1 Financing Led by Efung Capital, accelerating clinical progress in global competition for core pipelines | SHANGHAI, June 5, 2025 /PRNewswire/ -- Qure Biotechnology (Shanghai) Co., Ltd. (QureBio) announced that it has completed a Series C1 financing round. The financing raised nearly CNY 100 million (approximately USD 14 million) and was led exc... |
| 04.06.2025 | Health-care stocks are due for a turnaround after a historically bad month, according to the charts | - |
| 03.06.2025 | How Trump's Tariffs Are Reshaping Startups and Venture Capital Trump's 2025 tariffs have disrupted startups and VC markets, forcing founders to adapt through supply chain pivots, sector shifts, and al... | President Donald Trump's 2025 tariff policies — a 25% levy on goods from Canada and Mexico and a 10% duty on Chinese imports — sent shockwaves through the global economy. While framed as a strategy to bolster domestic manufacturing and curb... |
| 02.06.2025 | These are JPMorgan’s favorite stocks heading into June | - |
| 02.06.2025 | 10 ways the ‘Trump discount’ is hurting the stock market | - |
| 01.06.2025 | Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk | Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk
By Julie SteenhuysenJune 1, 20255:47 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
The logo for AstraZenec... |
| 31.05.2025 | Breast cancer: Pfizer-Arvinas drug beats AstraZeneca’s in delaying disease’s progression | - |
| 29.05.2025 | The Intersection of Biotechnology and Public Health: A Double-Edged Sword | In the world of healthcare, biotechnology stands as a beacon of hope. It’s a realm where science meets innovation, crafting solutions to age-old problems. Yet, this field is not without its shadows. Recent events highlight the delicate bala... |
| 29.05.2025 | China's biotech having its 'DeepSeek' moment amid big pharma M&A spree: ORI Capital founder | Global pharma giant Pfizer’s recent announcement of a record $1.25-billion upfront payment to buy the exclusive global license of Hong Kong-listed 3SBio’s cancer drug underscores the growing momentum displayed by big pharma towards investme... |
| 28.05.2025 | These biotech stocks will benefit as generative AI speeds up drug discovery, Jefferies says | - |
| 28.05.2025 | The rest of the world is trouncing the U.S. stock market. Why that could continue | - |
| 27.05.2025 | These strong stocks are under-owned and have momentum, Bank of America says | - |
| 25.05.2025 | Biotechnology Advancements: Revolutionizing Healthcare Through Innovation and Precision | Share
Share
Share
Share
Email
Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These innovations ar... |
| 23.05.2025 | Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting | CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced that its collaborator, Pfizer, will present an abstract ... |
| 23.05.2025 | Pfizer's 7.5% Dividend: Income Haven or House of Cards? Pfizer's high dividend yield warrants scrutiny regarding its sustainability, given changing revenues and pipeline investments. | - |
| 22.05.2025 | FDA panel is split on updates to COVID shots as questions loom for fall vaccinations | Other panelists noted that subtype is such a close relative that last year’s shots seem to offer cross-protection, at least for now but with no guarantee there wouldn’t be a different version circulating by the time a vaccination campaign r... |
| 22.05.2025 | Bayer, Pfizer, Other Big Global Firms Join Shanghai Open Innovation Initiative | (Yicai) May 22 -- The innovation centers of Germany's Bayer, US' Pfizer, Japan's Sony Group, Denmark's Novo Nordisk, and France's BioMérieux have joined the Group Open Innovation initiative of Pudong District of Shanghai.
The research and d... |
| 21.05.2025 | SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine | No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 to Russia
Company plans to export PCV13 vaccine components
"We aim for the global PCV market with our 21-valent... |
| 21.05.2025 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 20.05.2025 | Qorvo's Boardroom Shake-Up: A New Era Begins | In the fast-paced world of technology, change is the only constant. Qorvo, a prominent chipmaker, has recently made headlines by nominating Peter Feld from Starboard Value to its board. This move signals the end of a boardroom battle and a ... |
| 20.05.2025 | Cellcentric: $120 Million Raised For Treating Multiple Myeloma | CellCentric, a clinical-stage biotechnology company developing inobrodib (a first in class oral cancer drug to treat specific cancers, notably multiple myeloma) announced the completion of a $120 million Series C funding round. The funding ... |
| 20.05.2025 | New Trump vaccine policy limits access to COVID shots | It’s unclear what the upcoming changes mean for people who may still want a fall COVID-19 shot but don’t clearly fit into one of the categories.
“Is the pharmacist going to determine if you’re in a high-risk group?” asked Dr. Paul Offit, a ... |
| 19.05.2025 | Qorvo nominates Starboard's Peter Feld to board, ends boardroom battle | Chipmaker Qorvo said on Monday it will nominate activist investor Starboard Value's managing member Peter Feld to its board, ending a boardroom battle as the Apple supplier's stock shows signs of recovery.
Stiff competition and a shift in d... |
| 19.05.2025 | Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine | Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine
By ReutersMay 19, 202511:34 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 A box with the "Nuvaxovid... |
| 19.05.2025 | Qorvo nominates Starboard's Peter Feld to board, ends boardroom battle | Qorvo nominates Starboard's Peter Feld to board, ends boardroom battle
By ReutersMay 19, 202511:42 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A boardroom is seen in an office building in Ma... |
| 19.05.2025 | Origin: $21 Million Series A Raised For Global Benefits Intelligence Platform | Origin, the world’s first Global Benefits Intelligence platform, announced it officially launched and it has raised $21 million in Series A funding led by Felix Capital, with participation from Acadian Ventures and Notion Capital. And addit... |
| 17.05.2025 | Here are five ‘high quality’ stocks with major upside, according to Bank of America | - |
| 16.05.2025 | Origin's $21M Series A: A New Dawn for Employee Benefits Management | In the sprawling landscape of employee benefits, chaos often reigns. Companies juggle countless vendors, contracts, and policies, each a puzzle piece in a complex picture. Enter Origin, a UK-based startup that has just raised $21 million in... |
| 16.05.2025 | The Future of Test Automation: A New Era of Efficiency and Quality | In the fast-paced world of software development, time is a precious commodity. Companies are racing to deliver high-quality products faster than ever. Enter the partnership between TTC Global and ACCELQ, a game-changer in the realm of AI-po... |
| 15.05.2025 | A New Era for Australia and the EU: Political Shifts and Transparency Battles | In the ever-shifting landscape of global politics, two significant events have recently emerged from opposite ends of the world. Australia’s Prime Minister Anthony Albanese has secured a second term, while the European Court of Justice has ... |
| 15.05.2025 | UK-based Origin raises $21M Series A to tackle fragmented employee benefits | British startup Origin has launched out of stealth with $21 million in Series A funding. The round was led by Felix Capital, with participation from Acadian Ventures, Notion Capital, and a angel investors from across the HR, tech, and enter... |
| 15.05.2025 | Here are ‘Big Short’ Michael Burry’s latest moves in his portfolio | - |
| 14.05.2025 | Novavax's Path to Approval: A Vaccine's Journey Through Regulatory Hurdles | In the ever-evolving landscape of healthcare, Novavax is navigating a stormy sea. The company, known for its COVID-19 vaccine, is in talks with the FDA, seeking full approval. This dialogue is crucial. It’s the lifeline that could transform... |
| 14.05.2025 | European court sides with NYT over requests for von der Leyen’s texts with Pfizer CEO | The European Court of Justice found that the European Commission failed to explain why text messages with pharmaceutical giant Pfizer CEO should be kept private.
Berlaymont has been closely watching the highly anticipated legal ruling on tr... |
| 14.05.2025 | Bastyr University Lists Kenmore Washington Campus For Sale | Bastyr University Kenmore Campus
Bastyr University's Kenmore campus is being listed for sale today. The campus sits on more than 50 acres on the northeast shore of Lake Washington inside Saint Edward State Park. University leadership plans ... |
| 14.05.2025 | MARKETERS, MEET ELI: The Emotional Logic Interface That Predicts What Audiences Will Do Before They Do It | Eli From Sooth
A Proprietary AI System That Decodes Human Behavior and Purchasing Decisions, Eli Directs Brands on Who to Prioritize, What to Say and Where to Invest
NEW YORK, May 14, 2025 /PRNewswire-PRWeb/ -- Today, Sooth—the leader in pr... |
| 14.05.2025 | TTC Global and ACCELQ Join Forces to Transform AI-Powered Test Automation | TTC Global, a respected authority in software quality engineering solutions, has partnered with Dallas-based ACCELQ, the innovative AI-powered test automation platform, expanding their successful client engagement, including projects on the... |
| 13.05.2025 | Trump’s Drug Price Plan: A Bold Move or a Pipe Dream? | In a bold stroke, President Donald Trump has revived a controversial policy aimed at slashing U.S. drug prices. The plan, known as the “most favored nation” policy, seeks to tie American drug prices to those in other developed countries, wh... |
| 13.05.2025 | The Price of Health: Trump’s Bold Move Against Drug Costs | In a bold stroke, President Donald Trump has taken aim at the soaring prices of prescription drugs in the United States. His recent executive order targets weight-loss medications, specifically the popular drugs Wegovy and Zepbound. The goa... |
| 13.05.2025 |
Cramer’s Lightning Round: Energy Transfer is a buy | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Energy Transfer: [Buy, buy, buy!] The pipes... |
| 13.05.2025 | Trump executive order demands pharma industry price cuts | Trump executive order demands pharma industry price cuts
By Steve Holland, Michael Erman and Patrick WingroveMay 13, 202512:49 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
Tr... |
| 12.05.2025 | Trump signs order aiming to cut some U.S. drug prices to match lower ones abroad | President Donald Trump revived a controversial policy that aims to slash drug costs by tying the prices of some medicine in the U.S. to the significantly lower ones abroad.
Trump signed an executive order including several different actions... |
| 12.05.2025 | U.S. stocks with the most China revenue exposure that could win if long-term deal is reached | - |
| 09.05.2025 | The Pulse of Progress: Drug Discovery 2025 in Liverpool | The world of drug discovery is a vibrant tapestry, woven with threads of innovation, collaboration, and hope. This October, Liverpool will host Drug Discovery 2025, a pivotal event that promises to illuminate the path forward in life scienc... |
| 09.05.2025 | Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears | Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
By Sriparna RoyMay 8, 20259:34 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A woman holds a small bottle l... |
| 09.05.2025 | The number of ‘tariff’ mentions soar past ‘AI’ on earnings calls as Trump’s trade fight alters outlook | - |
| 07.05.2025 | The Landscape of Corporate Acquisitions: Saga Pure ASA's Bold Move | In the world of corporate acquisitions, the stakes are high, and the players are strategic. Saga Pure ASA recently made headlines with its mandatory offer to acquire all outstanding shares of S.D. Standard ETC Plc. This move is not just a t... |
| 07.05.2025 | The Pulse of Progress: DNB's First Quarter Presentation and BioStock Global Forum | In the world of finance and innovation, timing is everything. Two significant events loom on the horizon, each promising to shape the landscape of their respective industries. DNB's first quarter presentation and the BioStock Global Forum a... |
| 07.05.2025 | ELRIG announces keynote speakers for Drug Discovery 2025 | Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event
Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”
Event supported by VisitBritain showcases UK life science sector and ex... |
| 06.05.2025 | Reviving American Pharma: A Bold Move or a Risky Gamble? | In a landscape where the pharmaceutical industry has become a global chessboard, President Donald Trump has made a significant move. He signed an executive order aimed at revitalizing domestic drug manufacturing. This decision comes at a ti... |
| 06.05.2025 | Commentary: The world is a big step closer to preparing for future pandemics | Listen
8 min
New: You can now listen to articles.
This audio is generated by an AI tool.
SINGAPORE: While most are preoccupied with trade tensions and a fracturing world, a landmark moment in global cooperation has quietly happened.
After m... |
| 06.05.2025 | Pfizer, Novo, Novartis and Genmab are coming to BioStock Global Forum, are you? | Pfizer, Novo, Novartis and Genmab are coming to BioStock Global Forum, are you?
Tue, May 06, 2025 14:52 CET Report this content
Take the opportunity to connect with top life science investors and innovators during this rewarding two-day eve... |
| 06.05.2025 | Critic of drug industry and COVID-19 measures to lead FDA vaccine program | In a social media post, Prasad likened Marks to “a bobblehead doll that just stamps approval.”
Last year, he told former Republican presidential candidate Vivek Ramaswamy that Americans would probably be better off without the FDA in its cu... |
| 05.05.2025 | Trump signs order to boost domestic drug manufacturing as pharma tariffs loom | President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S.
The order comes ahead of Trump’s planned tariffs on pharmaceuticals imported into the U.S.
U.S. production in the pharmaceutical industry has shr... |
| 05.05.2025 | Trump team’s $500 million bet on old vaccine technology puzzles scientists | “This is not a next-generation vaccine,” said Rick Bright, who led HHS’ Biomedical Advanced Research and Development Authority, or BARDA, in the first Trump administration. “It’s so last-generation, or first-generation, it’s mind-blowing.”
... |
| 04.05.2025 | JPMorgan’s favorite stocks heading into May | - |
| 03.05.2025 | The Cost of Health: GLP-1s and the Future of Employer Healthcare | In the world of healthcare, costs often rise like a tide, relentless and overwhelming. But a new wave is forming, one that promises to reshape the landscape of employer-sponsored health plans. This wave is driven by GLP-1 medications, a cla... |
| 03.05.2025 | Eli Lilly and CVS Health: A Tale of Two Giants in the Pharmaceutical Arena | In the ever-evolving landscape of healthcare, two titans, Eli Lilly and CVS Health, have recently made headlines. Their stories are woven with threads of soaring sales, strategic pivots, and cautious optimism. Both companies navigate the st... |
| 02.05.2025 | AI offers vital support for dementia care but risks remain high | - |
